Contact us
|
Subscription service
|
Svenska
Search
Corporate governance
Investors & media
Pipeline
About Karo Bio
Site map
Home
/
Site map
Innovative pharmaceuticals for key medical needs
From knowledge to value for patients and owners
A pharmaceutical company with a sustainable profitability
Resources to guide projects to the market
Board of Directors
Executive management
Company history
2011 - 2012
2009 - 2010
2007 - 2008
2005 - 2006
2002 - 2004
1987 - 2001
Dictionary
Karo Bio Research Foundation
Vacant positions
Contact
Investors & media
Press releases
Financial Reports
Calendar
Largest shareholders
Share price
Analysts
Events/presentations
Subscription service
Image Library
Development pipeline
Nuclear receptors – regulate key functions
A compound for high blood lipids
Seminar: eprotirome/HeFH
Eprotirome - animation
Liver-selective antagonist for glucocorticoid receptors
A platform with many opportunities
GR inflammation
LXR inflammation
RORgamma
Protecting knowledge
Trademarks
Corporate governance
General meeting
Annual General Meeting 17 april 2011
Extra General Meeting 24 november 2010
Extraordinary General Meeting 10 november 2009
Special General Meeting 11 april 2007
Annual General Meeting 11 april 2007
Annual General Meeting 3 maj 2006
Special General Meeting 14 oktober 2005
Annual General Meeting 13 april 2005
Special General Meeting 30 augusti 2004
Annual General Meeting 21 april 2004
The Board of Directors’ work model
Nominating Committee for Annual Meeting of 2012
Audit
Board of Directors
Executive management
Incentive programs
Articles of association
Annual list of published information
